Różyńska, J. (2025). How Best to Interpret the Minimal Risk Threshold in the EU Regulation on Clinical Trials?”. Diametros, June, 1-27. https://doi.org/10.33392/diam.2028.
Różyńska, J. (2025). Research Payments, Other Collateral Benefits, and the Ethics of Imposing Research Risk. The American Journal of Bioethics, 25(5), 92–94. https://doi.org/10.1080/15265161.2025.2488286
Różyńska J. (2025) Collective Risks and the Social Disvalue of Research. The American Journal of Bioethics, 25(2), 90–3. https://doi.org/10.1080/15265161.2024.2441724
Kaczmarek, E. (2024). Self‐Deception in Human–AI Emotional Relations. Journal of Applied Philosophy. doi.org/10.1111/japp.12786
Różyńska, J., Zawiła-Niedźwiecki, J., Maćkiewicz, B., Czarkowski M. (2024). Tough Clinical Decisions: Experiences of Polish Physicians. HEC Forum 36: 111-130 (online first 2022).
Ramšak, M., Orzechowski, M., Bielińska, K., Chowaniec, A., et al. (2023). Diversity awareness, diversity competency and access to healthcare for minority groups: perspectives of healthcare professionals in Croatia, Germany, Poland, and Slovenia. Front. Public Health. 11:1204854. doi: 10.3389/fpubh.2023.1204854
Popa, E., Zawiła-Niedźwiecki, J. & Zabdyr-Jamróz, M. (2023) Policy change without ethical analysis? Commentary on the publication of Smajdor. Theoretical Medicine and Bioethics . https://doi.org/10.1007/s11017-023-09631-5
Łuków P. (2023) The ethical significance of consent to postmortem organ retrieval. Bioethics 37(5); 489-497.
Różyńska, J. (2023). A few remarks on limits of research risks and research payments. Medicine, Health Care and Philosophy 26, 155–156
Różyńska, J. (2023). How risky can biomedical research be?. In: Zima, T., Weisstub, D.N. (eds) Medical Research Ethics: Challenges in the 21st Century. Springer, Cham.
Łuków, P. (2023). Persons and Groups: Protection of Research Participants with Vulnerabilities as a Process. In: Zima, T., Weisstub, D.N. (eds) Medical Research Ethics: Challenges in the 21st Century. Springer, Cham.
Różyńska, J. (2022).The ethical anatomy of payment for research participants. Medicine Health Care and Philosophy 25, 449–464.
Łuków, P. (2022). Solidarity and the ethics of exposing others to risk in medical research. Bioethics 36(8): 821-828.
Różyńska, J. (2022). The principle of the primacy of the human subject and minimal risk in non-beneficial paediatric research. Bioethical Inquiry 19: 273–286.
Bielińska, K., Chowaniec, A., Doričić, et al. (2022). Equal access to healthcare in national legislations: how do Croatia, Germany, Poland, and Slovenia counteract discrimination in healthcare?. BMC Health Services Research, 22(1): 1-11.
Kaczmarek, E. (2022). Promoting diseases to promote drugs: the role of the pharmaceutical industry in fostering good and bad medicalization. British Journal of Clinical Pharmacology 88(1): 34-39.
Kaczmarek E. (2022). What Does Pricelessness Mean?, Journal of Value Inquiry 56, 469–484.
Makowska, M., Kaczmarek, E. & Rodzinka, M. (2022). Transparency or restricting gifts? Polish medical students’ opinions about regulating relationships with pharmaceutical sales representatives. Monash Bioethics Review 40 (Suppl 1), 49–70.
Różyńska, J. (2021). Taking the principle of the primacy of the human being seriously. Medicine, Health Care and Philosophy 24, 547–562
Różyńska, J. (2021). Research Participants Should Be Rewarded Rather than “Compensated for Time and Burdens”, The American Journal of Bioethics 21 (3): 52-54.
Łuków, P. (2021). Living with a transplant: Identity and a good life, In. Ethical Challenges of Organ Transplantation: Current Debates and International Perspectives, Eds. S. Hansen, S. Schicktanz. Transcript Verlag.
